A case report on Covid-19 infection

A previously healthy 30-year-old woman visited our psychiatric clinic for symptoms including anxiety, depression, insomnia, and brain fog (mild cognitive impairment) for more than 8 weeks after being diagnosed with COVID-19 o

COVID-19 treatment-induced neuropsychiatric adverse effects

COVID-19 represents a major challenge in the field of psychiatry, as both the virus and the medications used to treat it may induce neurologic and psychiatric symptoms. Antiretroviral drugs used for the treatment of COVID-19 may produce undesirable effects on the central and peripheral nervous systems. Cytochrome p450 enzymes are affected by protease inhibitors which […]

A Spectrum of COVID-19 Symptoms or Alzheimer’s?

COVID-19

A 67-year-old woman presented with the complaints of memory loss, difficulties in concentration especially during reading and cognitive fatigue after recent recovery from COVID-19 infection. The patient had a history of type 2 diabetes mellitus being managed with metformin. Her laboratory evaluation was normal except mild elevation of C-reactive protein. Her neuropsychological assessment revealed a […]

Association between COVID-19 and New-onset Epileptic Seizures

Name – American Academy of Neurology Annual Meeting (AAN 2021) (April 17 – April 22, 2021) Mode – Virtual A retrospective study conducted on COVID-19 patients, found a three times higher risk of novel seizures in those without a known history of epilepsy. Patients with new-onset seizures had longer hospital stays by 15 days and […]

Cardiovascular disease and COVID-19

Cardiovascular disease and COVID-19

Respiratory illness is the dominant clinical manifestation of COVID-19; CVD involvement occurs rarely. Acute cardiac injury, defined as a significant elevation of cardiac troponins, is the most commonly reported cardiac abnormality in COVID-19 affecting ~8–12% of patients. A Chinese study reported the incidence of heart failure in 52% of COVID-19 patients who subsequently died and […]